Loading...
Images of Bo Oberg
(0 from 0 )News
B-MS turns its back on HIV pact with Sweden's Medivir - PharmaTimes
www.pharmatimes.com
Sweden’s Medivir has been told that partner Bristol-Myers Squibb has terminated the development of the firms’ preclinical HIV compound MIV News -...
Swedish biotech licenses HIV drug to China for development ...www.aidsmap.com › news › feb › swedish-biotech-l...
www.aidsmap.com
Professor Bo Oberg, head of the HIV franchise at Medivir, told aidsmap: “This should enhance the safety of condoms and will at least save a few ...
sorted by relevance / date